Bristol-Myers Squibb is talent hunting at University of Copenhagen

The American pharmaceutical giant Bristol-Myers Squibb is talent scouting among Denmark’s brightest science talents, offering a new medical entrepreneurship course at the University of Copenhagen.

As the first large foreign company ever, Bristol-Myers Squibb is co-designing and financing a course at the Department of Health and Medical Sciences at the University of Copenhagen.

The new ‘medical entrepreneurship’ course aims at teaching students at the University of Copenhagen how to translate scientific discoveries into potential commercial successes. On top of financing the initiative, Bristol-Myers Squibb has offered to fly in teachers from the company’s headquarters in New York.

“It is exciting to be expanding our industry-university collaboration. This is a very effective way to teach students about innovation and entrepreneurship and to prepare them for the reality which they will soon be a part of”, says Dean Ulla Wewer from the Department of Health and Medical Sciences at the University of Copenhagen.

Bristol-Myers Squibb invests heavily in Danish biotech R&D

In the last 24 months, Bristol-Myers Squibb has invested more than 2.37 billion US Dollars in Danish biotech companies and Danish research, making the pharmaceutical company one of the biggest foreign investors in Denmark in recent years.

The course partnership with the University of Copenhagen will further add to this.

Course open from fall 2017

The first course programme is currently being developed with the working title Biopharma Entrepreneurship, which will be offered to graduate students from the fall semester 2017.

Students in the course will be awarded a number of ECTS credits. The ECTS (European Credit Transfer System) is a standard for comparing the study attainment and performance of students of higher education across the European Union and other collaborating European countries. 

Bristol-Myers Squibb will reward the two top students with a scholarship of 9,130 US Dollars (DKK 50,000).

Knowledge for pharmaceutical industry

The Danish Foundation for Entrepreneurship is also part of designing the medical entrepreneurship course at the University of Copenhagen.

We know that students who have been trained in translating ideas into solutions are more likely to become entrepreneurs and to start up a business. And even if they don’t, they will have gained valuable tools to develop ideas and discoveries to be used for product development in the established pharmaceutical industry”, says Director of The Danish Foundation for Entrepreneurship, Christian Vintergaard.